





BPC-157 · TB-500
Endurance, blood flow, recovery.
30-day full guarantee. Notice a difference or it's free — no return required.
What it does
Mechanism
Vascular support
BPC-157 modulates nitric-oxide synthase pathways — a 2026 human artery study confirmed an NO-mediated vasorelaxant effect.
Angiogenesis
Both peptides stimulate VEGF-driven new blood-vessel formation in injury models.
Recovery
The pairing is studied for endothelial repair and faster recovery between efforts.
The Evidence
These findings describe peer-reviewed research on BPC-157 · TB-500 — the active(s) in Peak Pulse. Claims are about the compound, not our formulation.
Yildirim et al. · J Clin Med 2026
Endothelium-dependent, nitric-oxide-mediated vasorelaxant effect of BPC-157 in human internal mammary artery (ex-vivo tissue).
PMID 42123221 — one of the first human-tissue datasets.
Wang et al. · Theranostics 2021
TB-500 activated the epicardium and enhanced repair of infarcted myocardium (animal model).
PMID 33754060.
Predominantly preclinical; no human endurance RCTs. TB-500 is WADA-prohibited in sport.
The Product
Your Peak Pulse pen, a 30-day supply of single-use needle tips, and bacteriostatic water for reconstitution — one discreet, unbranded box.




Questions
Ships as lyophilised powder in a sterile pen. Reconstitute once with the bacteriostatic water supplied, then administer a quick subcutaneous injection. Ships stable at ambient temperature; refrigerate on arrival.
Supplied for research and educational purposes. Not TGA-approved for therapeutic use and not sold as a medicine. Australian adults 18+ only.
Standard workplace and roadside screens test for recreational substances — peptides don't appear on them. If you compete under WADA rules, check the current prohibited list before use.
30-day full refund if you don't notice a difference. No return required.